Remove Bioinformatics Remove Disease Remove Drug Research
article thumbnail

Accelerating Drug Discovery Through Repurposing

DrugBank

In Silico Drug Repurposing Advances in bioinformatics and systems biology have fueled the rise of repurposing of in silico drugs. CMap utilizes gene expression profiles to connect drugs, genes, and diseases, enabling researchers to identify potential repurposing candidates based on their transcriptional signatures.

article thumbnail

Using clinical genomics and AI in drug development to elevate success

Drug Target Review

Biologics have gone from monoclonal antibodies to complex bi- and tri-specific antibodies, as well as antibody-drug conjugates. Cell and gene therapies offer patients the possibility of living a relatively normal lifetime, with potential cures for deadly diseases.